Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
- Shop
- Blog
-
About
About Tecan
Investors
Press Center
People
Publications
- Support
- Contact
- Life Sciences
- Diagnostics
- Partnering
- Language
Tecan Journal
Selected category: Biopharma & Drug Discovery
Back to overview
Designer chemotherapy
Brain tumors are the most common cause of mortality in childhood cancer patients, and treatment options are limited, especially for recurrent cases. Researchers at the University Hospital Düsseldorf are using automation to develop a more personalized approach to cancer medicine, performing rapid drug screening to identify novel therapeutic strategies to improve the chances of survival.
Perfecting technology for the NIH Roadmap
Scientists at Columbia University have created three flexible, fully automated workstations based on Freedom EVO® 200 platforms for the assay development work they are performing as part of the NIH Molecular Libraries Roadmap initiative.